Please try another search
Foresee Pharmaceuticals Co., Ltd., a clinical-stage pharmaceutical company, engages in the development and commercialization of drugs in the United States, China, and Europe. The company’s stabilized injectable formulation pipeline includes FP-001, which completed Phase III clinical study for the treatment of advanced stage prostate cancer; FP-004 that is in preclinical stage to treat opioids use disorder; FP-011 and FP-014, a long-acting sustained release dosage form for the treatment of breast cancer/prostate cancer; and FP-016 for the treatment of neurological diseases. Its new chemical entity pipeline products consist of FP-020 to treat sarcoidosis, idiopathic pulmonary fibrosis, and pulmonary emphysema; FP-025, a selective matrix metalloproteinase-12 inhibitor, which is in Phase II clinical trial for the treatment of asthma, chronic obstructive pulmonary diseases, and acute respiratory distress syndrome in COVID-19 patients; and FP-045, a selective aldehyde dehydrogenase (ALDH2) activator that completed Phase I clinical study for the treatment of fanconi anemia, as well as FP-040, an ALDH2 activator to treat central nervous system diseases. Foresee Pharmaceuticals Co., Ltd. was incorporated in 2013 and is based in Taipei, Taiwan.
Name | Age | Since | Title |
---|---|---|---|
Fu-Shiow Yin | - | 2016 | Independent Director |
Daria Mochly-Rosen | - | - | Member of Scientific Advisory Board |
Joseph P. Vacca | - | - | Member of Scientific Advisory Board |
Benjamin Chien | - | 2013 | Founder, CEO & Chairman |
Eric M. Gordon | - | - | Member of Scientific Advisory Board |
Wen-Chi Lee | - | 2016 | Independent Director |
Luo Ming Ling | - | 2015 | Supervisor |
Jia-Long Lee | - | 2015 | Director |
Jeff Wang | - | 2016 | Director |
Vincent Yen | - | 2013 | Representative Director |
Hank Lai | - | 2018 | Independent Director |
Ben Liu | - | 2023 | Independent Director |
Yisheng Lee | - | 2013 | Chief Medical Officer, Acting Head of Clinical Development & Representative Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review